These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2479564)

  • 1. The restrictive role of sialic acid in antigen presentation to a subset of human peripheral CD4+ T lymphocytes that requires antigen-presenting dendritic cells.
    Kapsenberg ML; Stiekema FE; Kallan A; Bos JD; Roozemond RC
    Eur J Immunol; 1989 Oct; 19(10):1829-34. PubMed ID: 2479564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen-presenting cells.
    Boog CJ; Neefjes JJ; Boes J; Ploegh HL; Melief CJ
    Eur J Immunol; 1989 Mar; 19(3):537-42. PubMed ID: 2785048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
    Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
    Grogg D; Hahn S; Erb P
    Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
    Dembic Z; Schenck K; Bogen B
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.
    Van Der Pouw Kraan TT; Stiekema FE; Teunissen MB; Bos JD; Kapsenberg L
    Immunology; 1989 Oct; 68(2):147-53. PubMed ID: 2572541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
    Guéry JC; Adorini L
    J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.
    Erb P; Grogg D; Troxler M; Kennedy M; Fluri M
    J Immunol; 1990 Feb; 144(3):790-5. PubMed ID: 1967273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
    Cruz PD; Bergstresser PR
    Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
    Wyss-Coray T; Brander C; Frutig K; Pichler WJ
    Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.
    Dang LH; Michalek MT; Takei F; Benaceraff B; Rock KL
    J Immunol; 1990 Jun; 144(11):4082-91. PubMed ID: 1971292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the role of leukocyte function-associated antigen-1 in activation of human influenza virus-specific T cell clones.
    Kuijpers KC; Kuijpers TW; Zeijlemaker WP; Lucas CJ; van Lier RA; Miedema F
    J Immunol; 1990 May; 144(9):3281-7. PubMed ID: 1970349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes.
    Thomas R; Davis LS; Lipsky PE
    J Immunol; 1993 Dec; 151(12):6840-52. PubMed ID: 8258694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific CD8+ cytolytic T cells by the exogenous bacterial antigen streptolysin O in rhesus monkeys.
    Chizzolini C; Millet PG; Olsen-Rasmussen MA; Collins WE
    Eur J Immunol; 1991 Nov; 21(11):2727-33. PubMed ID: 1682153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nickel-specific T lymphocyte clones derived from allergic nickel-contact dermatitis lesions in man: heterogeneity based on requirement of dendritic antigen-presenting cell subsets.
    Kapsenberg ML; Res P; Bos JD; Schootemijer A; Teunissen MB; Van Schooten W
    Eur J Immunol; 1987 Jun; 17(6):861-5. PubMed ID: 3496226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.